Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$24.25
+0.08%
Mkt Cap $3.89B
Analyst Ratings
Buy
10
Hold
3
Sell
0
Price Target (13 analysts)
$21.25
Range $20.00 – $22.00
Implied Upside
-12.4%
Consensus $21.25 vs current $24.25